Publications by authors named "B Mohty"

Claim this Profile
V
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics.
Amel Soua, Julia Gilhodes, Alexandre Iat, Yosr Hicheri, Colombe Saillard, Bilal Mohty

Eur J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia.
Guillaume Berton, Bochra Sedaki, Erwann Collomb, Sami Benachour, Michael Loschi, Bilal Mohty

Leuk Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
C Petit, C Saillard, B Mohty, Y Hicheri, F Villetard

Eur J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.
Sylvain Garciaz, Marie-Anne Hospital, Anne-Sophie Alary, Colombe Saillard, Yosr Hicheri, Bilal Mohty

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.
A Collignon, M A Hospital, C Montersino, F Courtier, A Charbonnier, B Mohty

Blood Cancer J· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis